Lack of efficacy of rituximab in Felty's syndrome

Míreanna Comhchosúla

• Anti-α-fodrin autoantibodies are not useful diagnostic markers of primary Sjögren's syndrome
  le: Sordet, C, et al.
  Foilsithe: (2005)
• Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations
  le: Aries, P M, et al.
  Foilsithe: (2006)
• Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases
  le: Gottenberg, J, et al.
  Foilsithe: (2005)
• Etanercept in treatment of Felty's syndrome
  le: Ghavami, A, et al.
  Foilsithe: (2005)
• Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome
  le: Seror, Raphaèle, et al.
  Foilsithe: (2007)